Rare diseases
Investigational molecules
Locations
4902 Headquarters Point Suite 300, 92121-5005, United States
Mirador Therapeutics Inc. focuses on inflammatory bowel disease research, with clinical interest centered on Crohn’s disease and ulcerative colitis. Its trial activity is directed toward gastrointestinal inflammation, mucosal healing, and the clinical features that define active disease in these conditions.
The sponsor’s research landscape includes assessment of disease control in both small bowel and colonic inflammatory presentations.
Mirador Therapeutics Inc. runs clinical trials in conditions such as Colitis ulcerative, Crohn's disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
